Diluted steroid facial wet wraps for childhood atopic eczema [4]

Dermatology

Volumn 200, Issue 4, 2000, Pages 338-339

  Tang, William Y M ^a,b  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b Department of Community Medicine   (Hong Kong)

Author keywords

Atopic eczema; Diluted steroid; Facial wet wraps

Indexed keywords

2 PHENOXYETHANOL; ELOMET; EMOLLIENT AGENT; LIQUID PARAFFIN; MOMETASONE FUROATE; STEROID;

ATOPIC DERMATITIS; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 0033934674     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018403     Document Type: Letter

References (13)

1. Larson FS, Holm NV, Henningen K: Atopic dermatitis: A genetic-epidemiological study in a population-based twin sample. J Am Acad Dermatol 1986;15:487-494.
2. Neame RL, Berth-Jones J, Kurinezuk JJ, Graham-Brown RA: Prevalence of atopic dermatitis in Leicester: A study of methodology and examination of possible ethnic variation. Br J Dermatol 1995;132:772-777.
3. Tang WY, Chan HH, Lam VM, Chong LY, Lo KK: Out-patient, short-term, once-daily, diluted, 0.1% mometasone furoate wet-wraps for childhood atopic eczema. J Dermatol Treat 1999;10:157-163.
4. Nicol NH: Atopic dermatitis: The (wet) wrap-up. Am J Nurs 1987;12: 1560-1563.
5. Goodyear HM, Spowart K, Harper JI: 'Wet-wrap' dressings for the treatment of atopic eczema in children (letter). Br J Dermatol 1991;125:604.
6. Mallon E, Powell S, Bridgman A: 'Wet-wrap' dressings for the treatment of atopic eczema in the community. J Dermatol Treat 1994;5:97-98.
7. Donald S: Know how: Wet wraps in atopic eczema. Nurs Times 1997;93: 67-68.
8. Twitchen LJ, Lowe AJ: Atopic eczema and wet-wrap dressings. Prof Nurse 1998;14:113-116.
9. Abeck D, Brockow K, Mempel M, Fesq H, Ring J: Treatment of acute exacerbated atopic eczema with emollient-antiseptic preparation using the 'wet wrap' ('wet pajama') technique (in German). Hautarzt 1999;50:418-421.
10. Oranje AP, Wolkerstorfer A, de Waard-van der Spek EB: Treatment of erythrodermic atopic dermatitis with 'wet-wrap' fluticasone propionate 0.05% cream/emollient 1:1 dressings. J Dermatol Treat 1999;10:73-74.
11. Michaeli-Cohen A, Neudorfer M, Loewenstein A, Lazar M, Geyer O: Case report: Visual loss caused by facial steroids. Can Fam Physician 1998;44: 2462-2463.
12. Prakash A, Benfield P: Topical mometasone: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 1998;55:145-163.
13. Wilkinson SM, Beck MH: Fluticasone propionate and mometasone furoate have a low risk of contact sensitization. Contact Dermatitis 1996;34:365-366.